Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Kestra Medical Technologies offers wearable medical devices which collects, store, and communicate patients vital performance data.
FoRx Therapeutics is a biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress pathways.
Protego Biopharma is a biotechnology company that develops therapeutics that aim to correct diseases caused by protein misfolding.
Alpine Immune Sciences is an immunotherapy company focused on developing treatments for autoimmune and inflammatory diseases.
Caldera Therapeutics is a biotech company engaged in the development of bispecific antibody CLD-423 for inflammatory bowel disease (IBD).
Alleviant Medical develops transcatheter technology designed to lift the clinical and economic burden of heart failure.
Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders
Rectify Pharmaceuticals is a biotechnology company developing Positive Functional Modulators (PFMs), disease-modifying therapeutics.
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.
Alveus Therapeutics is a clinical-stage biotech company developing therapies for obesity and metabolic diseases.
Spiro Medical is a medical device company developing a groundbreaking Pulmonary Neuromodulation (PNM) System for asthma treatment.
Alumis is a precision medicine company focused on the discovery, development and treatment of autoimmune disorders.
NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function.
BBOT is a clinical-stage biopharmaceutical company advancing a pipeline of novel therapeutics targeting RAS and PI3Kα malignancies.
ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines.
Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.
Senti Bio is a clinical-stage biotechnology company developing a new generation of cell and gene therapies for cancer.
Antares is a biotechnology company focused on developing transformational,medicines targeting validated cancer and other serious diseases.
Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.
Windward Bio develops monoclonal antibodies for advanced immunological diseases.
Replimune Group develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer.
Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.
XII Medical provides minimally invasive technology for obstructive sleep apnea.
Omega Funds has invested in 79 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Omega Funds's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 18 different industry categories.
Among tracked funding rounds, Alumis received $345.1M in a Post Ipo Equity round. Omega Funds's total known invested capital is $5.7B.
Omega Funds's average investment size is $96.1M across its portfolio of 79 companies.
Recent Omega Funds portfolio additions include Kestra Medical Technologies, Inc., FoRx Therapeutics, Protego Biopharma, Alpine Immune Sciences, Caldera Therapeutics. These companies were founded in 2020 or later.